FDA.reportPublic FDA data

Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet

RxCUI
1807886
RxNorm name
Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet
Display name
Hyoscyamine XR (Oral Pill)
Full name
Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet
Term type
SCD
Status
Active
Strength
0.375 mg
Dose form
Biphasic 12 HR XR Tab
Route
Oral Pill
Updated
2026-10-24 12:47:44

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102016
Active start
102016
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
hyoscyamine sulfate0.375 MG / 1 EACHhyoscyaminehyoscyamine sulfate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Extended Release Oral Tablet316945

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
hyoscyamine153970

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRBiphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet1NAMES
RxNorm NameBiphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSCD1ATTRIBUTES
RxCUI18078861CODES
MMSL_CODE
2 linked values
2CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4hyoscyamine
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine sulfate
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine sulfate
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine sulfate
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine sulfate
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine sulfate
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine sulfate
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine sulfate
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine sulfate
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine sulfate
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine sulfate
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine sulfate
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine sulfate
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine sulfate
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine sulfate
MEDRTD014202TremorDISEASEmay_treathyoscyamine
MEDRTD014202TremorDISEASEmay_treathyoscyamine sulfate
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine sulfate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine sulfate
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine sulfate
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.375 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUALITATIVE_DISTINCTIONBiphasic
ATTRIBUTESQUANTITY12 HR
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESVUID4032015
NAMESPrescribable Synonymhyoscyamine sulfate 0.375 MG Biphasic 12HR Extended Release Oral Tablet
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File